Big Pharma has pushed through a spate of price increases in recent weeks, and while all of them are sub-10%—the cap some companies have adopted—some of them will cost payers and consumers plenty. One of them, in fact, could be worth $1.2 billion all by itself.
Ook interessant voor je
Reageer